Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 38 of 561 for:    Recruiting, Not yet recruiting, Available Studies | Teaching

Implementation and Evaluation of a Perceptual Learning Module on the Identification of the Brachial Plexus (MAP-IS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03767010
Recruitment Status : Recruiting
First Posted : December 6, 2018
Last Update Posted : March 26, 2019
Sponsor:
Collaborator:
Université de Montréal
Information provided by (Responsible Party):
Centre hospitalier de l'Université de Montréal (CHUM)

Brief Summary:

Purpose:

This study is designed to:

  1. Implement a website hosting perceptual learning modules (PLMs)
  2. Implement and assess a PLM designed to improve the capacity of fourth-year medical students and first-year residents (novices) to locate the brachial plexus (BP) at the level of the interscalene groove on surface ultrasound images.

Hypothesis: The hypothesis of the study is that the PLM will improve the ability of novices to correctly locate the BP at the level of the interscalene groove on surface ultrasound images, compared to a control group.


Condition or disease Intervention/treatment Phase
Medical Education Other: Control (no PLM) Other: PLM Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 52 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Prospective, randomized, open-label study
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Implementation and Evaluation of a Perceptual Learning Module Aimed at Improving the Identification of the Brachial Plexus in the Interscalene Groove With Ultrasound
Actual Study Start Date : February 12, 2019
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : February 2020

Arm Intervention/treatment
Experimental: Control (no PLM)
Control: Pre, post, delayed test Participants will not do the PLM, but will perform a pretest, a posttest and a delayed test at 6 months
Other: Control (no PLM)
Pre, post, delayed test Participants will perform a pretest, a posttest and a delayed test at 6 months.

Experimental: Experimental (PLM)
Experimental: PLM group (pre, post, delayed test, PLM) Participants will do a pretest, the PLM, a posttest and a delayed test at 6 months
Other: PLM
PLM Participants will take the PLM on the location of the brachial plexus at the level of the interscalene groove on surface ultrasound images. They will also take a pretest, a post-test and a delayed test at 6 months. Pre, post, delayed test Participants will perform a pretest, a posttest and a delayed test at 6 months.




Primary Outcome Measures :
  1. Difference in correct locations of the BP between the pretest and the immediate post-test, for the Control group vs the PLM group. [ Time Frame: At baseline (pretest) and on the immediate post-test ]
    The BP for a case will be considered correctly located if the participant has placed a pointer inside a predefined "target zone", determined as representing the BP by three independent regional anesthesia experts.


Secondary Outcome Measures :
  1. Difference in the average distance of BP location [ Time Frame: At baseline (pretest) and on the immediate post-test ]
    Difference in the average distance of the participant's pointer relative to the target zone between the pretest and the immediate post-test, for the Control group vs the PLM group.

  2. Difference in correct locations of the BP [ Time Frame: At baseline (pretest) and on the delayed test at 6 months ]
    Difference in correct locations of the BP between the pretest and the delayed post-test, for the Control group vs the PLM group.

  3. Average response times during the various tests [ Time Frame: At baseline (pretest), on an immediate post-test, and on the delayed test at 6 months ]
    This measure represents the fluency or automaticity with which images are interpreted, and can be used to evaluate the cognitive effort deployed to make a reading. Training not only allows the expert to make an accurate location. It also allows the expert to do it quickly, and therefore with little cognitive effort, an essential attribute in clinical practice.

  4. For the PLM group only, the evolution of the participants' accuracy during the PLM [ Time Frame: During the PLM, at the end of the first on-line session ]
    The change in the participants' rate of correct answers as they progress through the PLM; indeed, since learners will evaluate all case blocks in the same order, we can estimate an average learning curve for our population (pretest vs block 1 vs block 2 vs post-test)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Fourth-year medical students and first-year residents having access to a computer with a high speed internet connection
  • Fourth-year medical students and first-year residents with no significant experience in ultrasound-guided regional anesthesia

Exclusion Criteria:

  • Smart phones and tablets will not be accepted due to their smaller screens.
  • Significant experience with ultrasound-guided regional anesthesia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03767010


Contacts
Layout table for location contacts
Contact: Arnaud Robitaille, MD, FRPC 514-890-8000 ext 12132 arnaud.robitaille@umontreal.ca
Contact: Monique Ruel, RN, CCRP 514-890-8000 ext 12171 monique.m.ruel.chum@ssss.gouv.qc.ca

Locations
Layout table for location information
Canada, Quebec
Centre hospitalier de l'Université de Montréal (CHUM) Recruiting
Montréal, Quebec, Canada, H2X 3E4
Contact: Arnaud Robitaille, MD, FRCP    514-890-8000 ext 12132    arnaud.robitaille@umontreal.ca   
Contact: Monique Ruel, RN, CCRP    514-890-8000 ext 12171    monique.m.ruel.chum@ssss.gouv.qc.ca   
Principal Investigator: Arnaud Robitaille, MD, FRCP         
Sponsors and Collaborators
Centre hospitalier de l'Université de Montréal (CHUM)
Université de Montréal
Investigators
Layout table for investigator information
Principal Investigator: Arnaud Robitaille, MD, FRPC Centre hospitalier de l'Université de Montréal (CHUM)

Layout table for additonal information
Responsible Party: Centre hospitalier de l'Université de Montréal (CHUM)
ClinicalTrials.gov Identifier: NCT03767010     History of Changes
Other Study ID Numbers: 18.275
First Posted: December 6, 2018    Key Record Dates
Last Update Posted: March 26, 2019
Last Verified: December 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No